Thermo Fisher Posts 3% Q2 Revenue Gain

Thermo Fisher Scientific (TMO 10.46%), a leader in life sciences tools and diagnostics, reported its second quarter 2025 results on July 23, 2025. The company outpaced expectations on both revenue and non-GAAP EPS, delivering $10.85 billion in revenue and $5.36 in non-GAAP EPS versus analyst estimates of $10.68 billion and $5.23, respectively. While revenue climbed by 3.0% from the prior year, operating margins tightened and free cash flow fell sharply, signaling growing pressures behind continued growth. O ...